It is notable from our rescue experiments that the tumor inhibiting effects of si‐METTL3 on DLBCL cells were reversed by NEDD1 in vitro and in vivo, further supporting that METTL3 is an upstream m6A modifier of NEDD1. Here, METTL3 is linked to diffuse large B-cell lymphoma.